Literature DB >> 1281152

Alternative splicing of the Oct-2 transcription factor RNA is differentially regulated in neuronal cells and B cells and results in protein isoforms with opposite effects on the activity of octamer/TAATGARAT-containing promoters.

K A Lillycrop1, D S Latchman.   

Abstract

The RNA encoding the octamer-binding transcription factor Oct-2 is alternatively spliced in both neuronal cells and in B cells to yield multiple mRNAs encoding different isoforms of the protein. We show that, compared with B cells, neuronal cells overexpress the mRNAs encoding Oct 2.4 and 2.5 which differ from the other forms (Oct 2.1, 2.2, and 2.3) at the C terminus of the protein. When introduced into cells lacking endogenous Oct-2, the various Oct-2 isoforms have different effects on octamer-containing promoters. The Oct 2.1, 2.2, and 2.3 forms stimulate all octamer-containing promoters. However, the Oct 2.4 and 2.5 forms can repress some promoters and stimulate others, depending on the sequence of the octamer motif and its context within the promoter. In contrast, when introduced into neuronal cells which express a high endogenous level of the inhibitory Oct 2.4 and 2.5 forms, all the Oct-2 isoforms can repress octamer-mediated gene expression. The significance of these findings is discussed with regard to the known inhibitory effect of the octamer motif on viral and cellular gene expression in neuronal cells.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1281152

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  29 in total

1.  Alternative splicing of the Brn-3a and Brn-3b transcription factor RNAs is regulated in neuronal cells.

Authors:  Y Z Liu; S J Dawson; D S Latchman
Journal:  J Mol Neurosci       Date:  1996       Impact factor: 3.444

2.  The different alternatively spliced isoforms of the Oct-2 transcription factor repress the involucrin promoter in a cell type-specific manner.

Authors:  C M Chapman; D S Latchman
Journal:  Mol Biol Rep       Date:  1998-11       Impact factor: 2.316

3.  The ability of POU family transcription factors to activate or repress gene expression is dependent on the spacing and context of their specific response elements.

Authors:  S J Dawson; Y Z Liu; B Rodel; T Möröy; D S Latchman
Journal:  Biochem J       Date:  1996-03-01       Impact factor: 3.857

Review 4.  Multiple steps in the regulation of transcription-factor level and activity.

Authors:  C F Calkhoven; G Ab
Journal:  Biochem J       Date:  1996-07-15       Impact factor: 3.857

5.  Adjacent proline residues in the inhibitory domain of the Oct-2 transcription factor play distinct functional roles.

Authors:  Y Z Liu; I K Lee; I Locke; S J Dawson; D S Latchman
Journal:  Nucleic Acids Res       Date:  1998-05-15       Impact factor: 16.971

6.  The POU-domain factor Brn-3.0 recognizes characteristic sites in the herpes simplex virus genome.

Authors:  E E Turner; J M Rhee; L T Feldman
Journal:  Nucleic Acids Res       Date:  1997-07-01       Impact factor: 16.971

7.  Activation of the herpes simplex virus immediate-early gene promoters by neuronally expressed POU family transcription factors.

Authors:  K A Lillycrop; Y Z Liu; T Theil; T Möröy; D S Latchman
Journal:  Biochem J       Date:  1995-04-15       Impact factor: 3.857

8.  A sequence compilation and comparison of exons that are alternatively spliced in neurons.

Authors:  S Stamm; M Q Zhang; T G Marr; D M Helfman
Journal:  Nucleic Acids Res       Date:  1994-05-11       Impact factor: 16.971

9.  The inhibitory domain in the Oct-2 transcription factor represses gene activity in a cell type-specific and promoter-independent manner.

Authors:  K A Lillycrop; D S Latchman
Journal:  Mol Biol Rep       Date:  1995       Impact factor: 2.316

10.  Oct-2 transcription factor binding activity and expression up-regulation in rat cerebral ischaemia is associated with a diminution of neuronal damage in vitro.

Authors:  Susanna Camós; Carme Gubern; Mónica Sobrado; Rocío Rodríguez; Víctor G Romera; María Ángeles Moro; Ignacio Lizasoain; Joaquín Serena; Judith Mallolas; Mar Castellanos
Journal:  Neuromolecular Med       Date:  2013-11-27       Impact factor: 3.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.